Activation of DNA damage response induced by the Kaposi’s sarcoma-associated herpes virus

5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The human herpes virus 8 (HHV-8), also known as Kaposi sarcoma-associated herpes virus (KSHV), can infect endothelial cells often leading to cell transformation and to the development of tumors, namely Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and the plasmablastic variant of multicentric Castleman's disease. KSHV is prevalent in areas such as sub-Saharan Africa and the Mediterranean region presenting distinct genotypes, which appear to be associated with differences in disease manifestation, according to geographical areas. In infected cells, KSHV persists in a latent episomal form. However, in a limited number of cells, it undergoes spontaneous lytic reactivation to ensure the production of new virions. During both the latent and the lytic cycle, KSHV is programmed to express genes which selectively modulate the DNA damage response (DDR) through the activation of the ataxia telangiectasia mutated (ATM) pathway and by phosphorylating factors associated with the DDR, including the major tumor suppressor protein p53 tumor suppressor p53. This review will focus on the interplay between the KSHV and the DDR response pathway throughout the viral lifecycle, exploring the putative molecular mechanism/s that may contribute to malignant transformation of host cells.

Cite

CITATION STYLE

APA

Di Domenico, E. G., Toma, L., Bordignon, V., Trento, E., D’Agosto, G., Cordiali-Fei, P., & Ensoli, F. (2016, June 1). Activation of DNA damage response induced by the Kaposi’s sarcoma-associated herpes virus. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms17060854

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free